References
- ToruMMatsudaOMakiguchiKSuganoKNeuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugsJ Nerv Ment Dis19811693243276111584
- GhoshRLiddleBJEmergency presentations of Parkinson’s disease: early recognition and treatment are crucial for optimum outcomePostgrad Med J20118712513121106801
- GraceJBThompsonPNeuroleptic malignant like syndrome in two patients on holinesterase inhibitorsInt J Geriatr Psychiatry20062119219416440372
- ReimerJKuhlmannAMüllerTNeuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolideParkinsonism Relat Disord2002911511612473402
- BonniciARuinerCESt-LaurentLHornsteinDAn interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stayAnn Pharmacother2010441504150720628041
- OgawaESakakibaraRKishiMTatenoFConstipation triggered the malignant syndrome in Parkinson’s diseaseNeurol Sci20123334735021773844
- IkebeSHaradaTHashimotoTPrevention and treatment of malignant syndrome in Parkinson’s disease: a consensus statement of the malignant syndrome research groupParkinsonism Relat Disord200394749
- HashimotoTTokudaTHanyuNTabataKYanagisawaNWithdrawal of levodopa and other risk factors for malignant syndrome in Parkinson’s diseaseParkinsonism Relat Disord200392530
- UedaMHamamotoMNagayamaHOkuboSAmemiyaSKatayamaYBiochemical alterations during medication withdrawal in Parkinson’s disease with and without neuroleptic malignant-like syndromeJ Neurol Neurosurg Psychiatry20017111111311413275
- NisijimaKElevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two casesNeuropsychiatr Dis Treat2012861561823271911
- SachdevPKrukJKneeboneMKissaneDClozapine-induced neuroleptic malignant syndrome: review and report of new casesJ Clin Psychopharmacol1995153653718830069